Skip to content

Microbiome Analysis of Skin and Airway Samples and Effect of Face Masks

Effect of Face Masks on the Microbial Communities of the Skin and Upper Airways and the Optimalisation of Microbiome Analysis

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04894422
Enrollment
100
Registered
2021-05-20
Start date
2021-03-15
Completion date
2023-03-15
Last updated
2021-05-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Keywords

skin microbiome, 16S amplicon sequencing, face masks, upper airway microbiome, shotgun sequencing

Brief summary

The goal of this study is to optimize two methods for microbiome analysis of skin and upper airway samples (16S amplicon sequencing and Shotgun sequencing). In addition, the researchers will investigate whether there is an effect of wearing a face mask on the microbial communities of the skin and upper airways. The volunteers will self-collect swabs of the skin and upper airways (nose and/or throat). Bacterial DNA and/or total RNA will be isolated and the microbial communities will be investigated with 16S amplicon sequencing and shotgun metagenomic sequencing.

Interventions

Voluntarily (not) wearing a face mask (cotton or surgical) for 4 hours, following the government's guidelines during the COVID-19 pandemic.

Sponsors

Universiteit Antwerpen
CollaboratorOTHER
University Hospital, Antwerp
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Adult age 18 at the start of the study

Exclusion criteria

* Pregnant women

Design outcomes

Primary

MeasureTime frameDescription
Optimalization of microbiome analysis of skin and upper airway samplesStart16S rRNA sequencing, shotgun metagenomic sequencing
Change from baseline in microbiome composition of the skin and upper airways after wearing a face maskStart, 4 hours16S rRNA sequencing

Countries

Belgium

Contacts

Primary ContactSarah Lebeer, Prof.
sarah.lebeer@uantwerpen.be+3232653285
Backup ContactVeronique Verhoeven, Prof. Dr.
veronique.verhoeven@uantwerpen.be+3232652518

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026